SHIVA SHARMA: Open Payments
NPI 1619243193 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130,637 in 157 payments from 7 companies in 2025. Trend: 2023 $46 · 2024 $8,996 · 2025 $130,637
Speaker / faculty: $88,714Travel & lodging: $27,544Honoraria: $12,100Food & beverage: $2,279
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 109 | $99,692 |
| Otsuka America Pharmaceutical, Inc. | 26 | $17,214 |
| Axsome Therapeutics, Inc. | 16 | $13,476 |
| Janssen Scientific Affairs, LLC | 3 | $209 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
Products named: UZEDY, ABILIFY MAINTENA, AUSTEDO XR, Auvelity, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across NM — which companies pay providers there.
